FOXO1 and rhabdomyosarcoma: The receptor tyrosine kinase, IGF2 is another potential target, given that either loss of imprinting or PAX-FOXO1-driven gene expression can induce the overexpression of IGF2 in rhabdomyosarcoma tumors (111).